InvestorsHub Logo
Followers 3
Posts 582
Boards Moderated 0
Alias Born 01/19/2012

Re: None

Sunday, 05/20/2018 10:45:48 PM

Sunday, May 20, 2018 10:45:48 PM

Post# of 7730
Early strategic licenses and acquisitions

apalutamide (ARN-509)

erdafitinib (FGFR inhibitor)

JNJ-9375 (anti-thrombin)

pimodivir (JNJ-3872)

JNJ-4178 (3DAA)

imetelstat

niraparib

JNJ-5111 (HM12525A)

JNJ-2463 (CB1 inverse agonist)

JNJ-7107 (CD40 agonist)

talacotuzumab (CSL362)

duvortuximab (MGD011)

JNJ-1860 (ExPEC vaccine)

JNJ-7957 (BCMA x CD3)

lumicitabine (JNJ-1575)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News